Go Deep
ResMed Inc.
ResMed Inc. Score & Ratio Trend
| Date | Score | P/E | P/B | D/E | Price |
|---|---|---|---|---|---|
| Oct 2026 | 19,166 | 22.1 | 4.91 | 0.12 | 22,215.51 |
| Oct 2026 | 18,780 | 22.5 | 5.01 | 0.12 | 22,460.73 |
| Oct 2026 | 18,830 | 22.5 | 5.02 | 0.12 | 22,383.73 |
| Oct 2026 | 18,823 | 22.6 | 5.03 | 0.12 | 22,340.20 |
| Oct 2026 | 18,623 | 23.2 | 5.17 | 0.12 | 23,002.41 |
| Oct 2026 | 18,717 | 22.9 | 5.10 | 0.12 | 22,634.03 |
| Oct 2026 | 18,694 | 23.0 | 5.12 | 0.12 | 22,734.13 |
| Oct 2026 | 18,529 | 23.5 | 5.24 | 0.12 | 23,277.42 |
| Oct 2026 | 18,509 | 23.6 | 5.26 | 0.12 | 23,286.13 |
| Oct 2026 | 18,311 | 24.3 | 5.40 | 0.12 | 23,886.54 |
| Oct 2026 | 18,317 | 24.2 | 5.40 | 0.12 | 23,966.62 |
ResMed Inc. Quarterly Results
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 |
|---|---|---|---|---|
| Revenue | 1,463,647,000.0 | 1,431,406,000.0 | 1,422,808,000.0 | 1,335,582,000.0 |
| Net Profit | 383,432,000.0 | 398,732,000.0 | 392,593,000.0 | 348,536,000.0 |
| EPS | 2.6 | 2.7 | 2.7 | 2.4 |
ResMed Inc. Revenue & Profit: Last 5 Years
| Line Item | Jun 2026 | Jun 2025 | Jun 2024 | Jun 2023 | Jun 2022 |
|---|---|---|---|---|---|
| Revenue | 5,653,443,000.0 | 5,146,327,000.0 | 4,685,297,000.0 | 4,222,993,000.0 | — |
| Net Profit | 1,523,293,000.0 | 1,400,723,000.0 | 1,020,951,000.0 | 897,556,000.0 | — |
| EPS | — | — | 6.9 | 6.1 | 5.3 |
ResMed Inc. Balance Sheet
| Line Item | Jun 2026 | Jun 2025 | Jun 2024 | Jun 2023 | Jun 2022 |
|---|---|---|---|---|---|
| Total Assets | 8,965,950,000.0 | 8,174,391,000.0 | 6,872,394,000.0 | 6,751,708,000.0 | — |
| Total Liabilities | 2,380,557,000.0 | 2,206,532,000.0 | 2,008,351,000.0 | 2,621,805,000.0 | — |
| Total Equity | 6,585,393,000.0 | 5,967,859,000.0 | 4,864,043,000.0 | 4,129,903,000.0 | — |
Owes vs Owns
ResMed Inc. owed $0.27 for every $1 it owned in Jun 2026, down from $0.39 in Jun 2023.
| Period | Jun 2026 | Jun 2025 | Jun 2024 | Jun 2023 |
|---|---|---|---|---|
| Owes vs Owns | 0.27× | 0.27× | 0.29× | 0.39× |
Everything the company owes ÷ everything it owns. Below 1× it owns more than it owes; above 1× it owes more than it owns.
ResMed Inc. Assets & Liabilities Breakdown (USD millions)
What it owns — Jun 2026
Cash & short-term investments 16.4%Receivables 12.1%Inventory 10.5%Fixed assets (tangible) 8.2%Intangible assets 37.5%Other assets 15.3%
How it's funded — Jun 2026
Short-term debt 2.9%Long-term debt 4.5%Payables 3.4%Other liabilities 15.8%Shareholders' equity 73.4%
| Line Item | Jun 2026 | Jun 2025 | Jun 2024 | Jun 2023 |
|---|---|---|---|---|
| Assets | ||||
| Cash & short-term investments | 1,469.2 | 1,209.5 | 238.4 | 227.9 |
| Receivables | 1,085.0 | 990.7 | 875.5 | 704.9 |
| Inventory | 945.8 | 927.7 | 822.2 | 998.0 |
| Fixed assets (tangible) | 735.0 | 718.3 | 699.1 | 665.8 |
| Intangible assets | 3,362.3 | 3,511.5 | 3,328.0 | 3,322.6 |
| Long-term investments | 0.0 | 0.0 | 0.0 | 0.0 |
| Other assets | 1,368.7 | 816.7 | 909.2 | 832.4 |
| Liabilities & equity | ||||
| Short-term debt | 259.9 | 9.9 | 9.9 | 9.9 |
| Long-term debt | 399.4 | 658.4 | 697.3 | 1,431.2 |
| Payables | 308.9 | 278.2 | 237.7 | 150.8 |
| Other liabilities | 1,412.3 | 1,260.1 | 1,063.4 | 1,029.9 |
| Shareholders' equity | 6,585.4 | 5,967.9 | 4,864.0 | 4,129.9 |
| Net tangible assets | 3,223.1 | 2,456.3 | 1,536.1 | 807.3 |
ResMed Inc. Cash Flow
| Line Item | Jun 2026 | Jun 2025 | Jun 2024 | Jun 2023 | Jun 2022 |
|---|---|---|---|---|---|
| Operating Activities | 1,805,829,000.0 | 1,751,588,000.0 | 1,401,260,000.0 | 693,299,000.0 | — |
| Investing Activities | -545,199,000.0 | -200,045,000.0 | -269,784,000.0 | -1,159,845,000.0 | — |
| Financing Activities | -1,007,029,000.0 | -606,253,000.0 | -1,119,287,000.0 | 422,874,000.0 | — |